MarketsNotableSingle-sourceDeveloping
5.1
Yarrow Bioscience files 8-K disclosing acquisition, management changes, and equity issuance
SEC EDGAR 8-K FilingsLO·US·about 2 hours ago
Cross Country Healthcare Inc. filed an 8-K disclosing a change in control, termination of a material agreement, and potential delisting issues. The filing indicates a significant corporate transition, though specific details regarding the acquirer or the nature of the delisting notice remain to be synthesized from the full document.
Locations
Entities